Stonepine Capital Management, LLC
CIK 1440771 · Holdings on Mar 31, 2026 · First reported May 14, 2026
Top ten holdings
Q1 2026- VSTM15.39%
- TENX13.72%
- EOLS6.36%
- ADMA5.86%
- CAMP5.39%
- NKTR5.38%
- ZVRA3.93%
- CRBP3.17%
- ABEO2.94%
- KZIA2.26%
Share classes counted separately64.40%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- TENXWeight increased · +13.61 pp0.11% → 13.72%Shares +963.32K (+8105.99%)
- ADMAWeight decreased · -4.82 pp10.68% → 5.86%Shares 0 (0.00%)
- CAMPWeight increased · +4.28 pp1.11% → 5.39%Shares +1.16M (+507.10%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | VSTMVERASTEM INCCOM NEW View history and evidence | $17.50M | 15.39% | 3.30M shares | 16.68% → 15.39%-1.29 pp +570.22K (+20.87%) | Added | ↗▾ |
| 02 | TENXTENAX THERAPEUTICS INCCOM NEW View history and evidence | $15.59M | 13.72% | 975.20K shares | 0.11% → 13.72%+13.61 pp +963.32K (+8105.99%) | Added | ↗▾ |
| 03 | EOLSEVOLUS INC View history and evidence | $7.23M | 6.36% | 1.76M shares | 8.58% → 6.36%-2.22 pp +127.50K (+7.81%) | Added | ↗▾ |
| 04 | ADMAADMA BIOLOGICS INC View history and evidence | $6.67M | 5.86% | 740.00K shares | 10.68% → 5.86%-4.82 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | CAMPCAMP4 THERAPEUTICS CORP View history and evidence | $6.13M | 5.39% | 1.39M shares | 1.11% → 5.39%+4.28 pp +1.16M (+507.10%) | Added | ↗▾ |
| 06 | NKTRNEKTAR THERAPEUTICSCOM NEW View history and evidence | $6.12M | 5.38% | 85.00K shares | 2.84% → 5.38%+2.54 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | ZVRAZEVRA THERAPEUTICS INCCOM NEW View history and evidence | $4.47M | 3.93% | 480.00K shares | 4.03% → 3.93%-0.10 pp -89.09K (-15.65%) | Reduced | ↗▾ |
| 08 | CRBPCORBUS PHARMACEUTICALS HOLDICOM NEW View history and evidence | $3.60M | 3.17% | 383.46K shares | 2.51% → 3.17%+0.66 pp -6.45K (-1.66%) | Reduced | ↗▾ |
| 09 | ABEOABEONA THERAPEUTICS INCCOM NEW View history and evidence | $3.34M | 2.94% | 746.59K shares | 2.96% → 2.94%-0.02 pp +37.08K (+5.23%) | Added | ↗▾ |
| 10 | KZIAKAZIA THERAPEUTICS-SPON ADRSPONSORED ADS View history and evidence | $2.57M | 2.26% | 345.18K shares | 2.51% → 2.26%-0.25 pp -115.18K (-25.02%) | Reduced | ↗▾ |
Options overlay 17
$136.03M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
XBISS SPDR S&P BIOTECH ETFSTATE STREET SPD View history and evidence | Put | 400.00K | $51.09M | +400.00K | ▾ |
XBISS SPDR S&P BIOTECH ETFSTATE STREET SPD View history and evidence | Call | 400.00K | $51.09M | +400.00K | ▾ |
ADMAADMA BIOLOGICS INC View history and evidence | Call | 1.15M | $10.36M | +1.15M | ▾ |
3 / 17 options · preview only
Exited positions 18
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| INDV INDIVIOR PLC | Non-derivative | -100,000 | -$3.59M | SEC filing ↗ | SEC filing ↗ |
| ACAD ACADIA PHARMACEUTICALS INC | Non-derivative | -100,000 | -$2.67M | SEC filing ↗ | SEC filing ↗ |
| CRSP CRISPR THERAPEUTICS AG | Call | -50,000 | -$2.62M | SEC filing ↗ | SEC filing ↗ |
3 / 18 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1440771 · Period 2026-03-31
Data loaded 2026-09-23 · First reported 2026-05-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 249722452
}Research all 83 reported holdings.
This page includes 30 of 83 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 83 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1440771","quarter":"2026Q1","page_size":100}
get_institutional_manager_history
{"cik":"1440771","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.